FBCE yields 2000000.00% · MRK yields 2.76%● Live data
📍 FBCE pulled ahead of the other in Year 1
Combined, FBCE + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FBCE + MRK for your $10,000?
FiberCore, Inc. develops, manufactures, and markets single-mode and multimode optical fiber, and optical fiber preforms for the telecommunications and data communications industry. The company's principal operating units are FiberCore Jena A.G. (FCJ), its wholly owned subsidiary in Germany; and Xtal FiberCore Brasil S.A. (Xtal), the company's 90% owned subsidiary in Campinas, Brazil. FCJ manufactures both multimode and single-mode fiber and preforms with an emphasis on the multimode market; Xtal manufactures both single-mode and multimode fiber, and single-mode preforms with an emphasis on the single-mode market. Through its subsidiary, FiberCore Systems, Inc., the company designs, installs, and maintains optical fiber networks, wide area networks, and non-fiber optic networks primarily in the Northeast U.S., for local area network applications, such as those used in hospitals, universities, government, and commercial buildings. The company markets its optical fiber products under the trademarks, InfoGlas®, EconoGrade®, and ValuGrade®. Fibercore competes with Corning, Inc.; Furukawa/OFS; Alcatel; Draka; Samsung; and Sumitomo. FiberCore, Inc. was founded in 1987 and is based in Charlton, Massachusetts. On October 6, 2004 the voluntary petition of FiberCore, Inc. for reorganization under Chapter 11 was converted to liquidation under Chapter 7. The Company had filed for Chapter 11 on November 14, 2003.
Full FBCE Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.